Security Bank Corp. reported a three-percent improvement in net income to ₱11.6 billion last year as net interest income grew while non-interest ...
Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) to be completed by our partner Jazz in first-line ...
Held Type A meeting with FDA to discuss AMT-130 for Huntington's disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results